Navigation Links
Survivors of Holocaust More Likely to Have Cancer

Survivors of the Holocaust are more likely to suffer from cancer and die from it, researchers say.

Nani Vine Raviv and his colleagues at Israel's //Haifa University suspect that cancers are most likely caused by the near-starvation of European Jews during World War II.

The researchers looked at the incidence and death rate from cancer in around four million Israelis of European origin - comparing those who emigrated from Europe before 1939 with those who arrived in Israel after the war ended in 1945.

Those who had been in Europe during the Holocaust were more than twice as likely to suffer cancer later in life, and up to 13 percent less likely to survive the disease.

Some cancers were particularly common among Holocaust survivors, they found.

For example, cancer of the large intestine was nine times likely to afflict male survivors.

'The age at which Jewish people experienced the Holocaust was important', Micha Barchana of Israel's National Cancer Registry was quoted as saying by the New Scientist.

'Girls who were less than 10 years old during the war were twice as likely to get breast cancer as those who were adults at the time,' said Barchana, who was also involved in the study.

Barchana hopes the study will lead to greater awareness of the cancer risks faced by Holocaust survivors, and improved detection.

According to him, one reason for the higher death rates may be that many survivors get diagnosed later, so recovery rates are worse.

'Perhaps they have had so much suffering in their lives that they cannot face up to the possibility of cancer,' he says.

(Source: IANS News)
'"/>




Page: 1

Related medicine news :

1. Breast Cancer Survivors Worry About Infertility
2. Breast Cancer Survivors Worry About Infertility
3. An Incentive For Breast Cancer Survivors
4. Better Care Required for Breast Cancer Survivors
5. Exercising Good For Stroke Survivors
6. Tsunami Survivors Face Pneumonia Threat
7. Survivors of childhood cancer may have long-term health problems
8. Encephalitis Survivors Face The Risk Of Becoming Disabled
9. Socialization A Serious Trouble For Childhood Cancer Survivors
10. Pakistani Quake Survivors Face Outbreak Of Diarrhea
11. Chronic Post-Traumatic Stress Disorder (PTSD) Risk In Young Natural Disaster Survivors
Post Your Comments:
(Date:1/9/2009)...e of 300 calories every day, study finds, , ...,re like many Americans, soda and coffee drinks ha...e findings from a new study may make you drop that...n the January issue of The American Journal of C... are now drinking almost 50 additional calories of...
(Date:1/9/2009)...ewswire-USNewswire/ -- The Society of Gynecologic ...g on Women,s Cancer, February 5-8, 2009 at the Hen...exas. This year,s meeting will feature more than ...es, workshops, symposia, surgical labs and postgra...ical trials and treatment advances for physicians ...
(Date:1/9/2009)...9 Pierre,s Ice Cream Company, make...et, is launching another innovation,called Yovati...gi-bin/prnh/20090109/CLF014 ) , Yovation(T... was inspired,by the growing consumer interest an...ition by the medical community of the benefits of ...
(Date:1/9/2009)... 9 Palmetto GBA, a lead...ces for the federal government, has been selected ... Services (CMS) to process and pay all fee-for-ser...r South Carolina, North Carolina, Virginia and Wes...ve process, CMS awarded Palmetto GBA a contract wi...
Breaking Medicine News(10 mins):Health News:Americans Consuming More Sugary Beverages 2Health News:Americans Consuming More Sugary Beverages 3Health News:Society of Gynecologic Oncologists to Host 40th Annual Meeting on Women's Cancer 2Health News:Standing Ovation for Pierre's New Innovation! 2Health News:Standing Ovation for Pierre's New Innovation! 3Health News:CMS Selects Palmetto GBA to Administer Medicare Program in Four States 2
...sts have found that consumption of spicy food dail...an be killed by Capsaicin, the chemical that is re... also feel that Capsaicin may provide the answer t...f Nottingham scientists claim that this chemical t...
...uals who take in higher levels of the nutrient fol...educed risk of developing Alzheimer’s disease//, a...ves of Neurology, one of the JAMA/Archives journal... Alzheimer’s disease is expected to quadruple, acc...
...ncer drugs have been created from blue green algae...mistry techniques//. Besides this, the information...n into consideration. This accomplishment is expe...duce enough of the promising drugs for use in clin...
...ns to improve the treatment given to people bitten... assigned for this mission//. Africa, Latin Ameri...ms of rabies, snake bite and scorpion stings. When... of death is not known as many of them prefer home...
Other Medicine News:Health News:Higher Folate Levels Linked to Reduced Risk for Alzheimer’s Diseas 2Health News:Anti Cancer Drug from Blue Green Algae 2
(Date:1/8/2009)...l dose in an ongoing Phase Ib trial demonstrated a...ays , , Conference Call Today at 8:30AM EST ,...nadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) toda...going Phase Ib clinical trial of ANA598, the Compa...ibitor. ANA598 was very well-tolerated and demons...
(Date:1/7/2009)...wire-USNewswire/ -- Scientists have identified mut... relapse in children with acute lymphoblastic leuk...further research is needed to determine how change... leukemia relapse, the findings are likely to prov...s the risk of treatment failure. By using a molecu...
(Date:1/7/2009)...wire/ -- ImQuest Life Sciences announced today the...e Food and Drug Administration to initiate human c...inhibitor IQP-0410. ImQuest anticipates initiating...9. IQP-0410 is a novel small molecule inhibitor of...se transcriptase inhibitor (NNRTI). The compound p...
(Date:1/7/2009)...- Tiantan Puhua Hospital Stem Cells Center ( http:...n using stem cells to effectively treat neurologic...erienced additions to its medical and research sta...ent capabilities for growing numbers of incoming i...ude the distinguished Dr. Jiang Ping, who was name...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Mitigating Medical Identity Theft 3A AHIMA Journal Provides Patient Tools to Secure Health Information 23459 1Mitigating Medical Identity Theft 3A AHIMA Journal Provides Patient Tools to Secure Health Information 23459 2Mitigating Medical Identity Theft 3A AHIMA Journal Provides Patient Tools to Secure Health Information 23459 3Two National Health Organizations to Recognize the Nations Best Health Systems for Patient Safety Leadership 23457 1Two National Health Organizations to Recognize the Nations Best Health Systems for Patient Safety Leadership 23457 2Two National Health Organizations to Recognize the Nations Best Health Systems for Patient Safety Leadership 23457 3Study Measures Real World Comparative Effectiveness of Asthma Controller Medications 23455 1Study Measures Real World Comparative Effectiveness of Asthma Controller Medications 23455 2Study Measures Real World Comparative Effectiveness of Asthma Controller Medications 23455 3Study Measures Real World Comparative Effectiveness of Asthma Controller Medications 23455 4Associates of Cape Cod 28ACC 29 and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform 23453 1Associates of Cape Cod 28ACC 29 and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform 23453 2Associates of Cape Cod 28ACC 29 and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform 23453 3
...ddress Growing Problem of Antibiotic Resistance,Pu...h Columbia, March 26, 2007 /PRNewswire/ --,Inimex ...the first,immune system trigger to cure infections...o a paper published in the April 2007,issue of Nat...he work of Inimex and its,co-founders Dr. Bob Hanc...
... Outpatient Infusion Study in Patients with,Chroni...rican,College of Cardiology 56th Annual Scientific..., March 25, 2007,/PRNewswire/ -- Scios Inc. announ...2 study of nesiritide (NATRECOR(R)) showed a,neutr...death and,cardiorenal hospitalization at 12 weeks,...
Other Medicine Technology:Inimex Product Candidate is First Immune Defense Regulator to Cure,Infections Without Causing Harmful Inflammation 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7
Sera available in three levels for the control of accuracy and precision for up to 31 analytes
Human based material available in two levels for the control of accuracy and precision for upto 23 analytes.
CRP Liquid Conrtols level 2
The AST method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma
Medicine Products: